Peripheral nerve transfers change target muscle structure and function
Journal article, 2019

Selective nerve transfers surgically rewire motor neurons and are used in extremity reconstruction to restore muscle function or to facilitate intuitive prosthetic control. We investigated the neurophysiological effects of rewiring motor axons originating from spinal motor neuron pools into target muscles with lower innervation ratio in a rat model. Following reinnervation, the target muscle's force regenerated almost completely, with the motor unit population increasing to 116% in functional and 172% in histological assessments with subsequently smaller muscle units. Muscle fiber type populations transformed into the donor nerve's original muscles. We thus demonstrate that axons of alternative spinal origin can hyper-reinnervate target muscles without loss of muscle force regeneration, but with a donor-specific shift in muscle fiber type. These results explain the excellent clinical outcomes following nerve transfers in neuromuscular reconstruction. They indicate that reinnervated muscles can provide an accurate bioscreen to display neural information of lost body parts for high-fidelity prosthetic control.

Author

Konstantin D Bergmeister

Medical University of Vienna

Martin Aman

Medical University of Vienna

Silvia Muceli

University Medical Center Göttingen

Imperial College London

Ivan Vujaklija

Imperial College London

Krisztina Manzano-Szalai

Medical University of Vienna

Ewald Unger

Medical University of Vienna

Ruth A. Byrne

Medical University of Vienna

Clemens Scheinecker

Medical University of Vienna

Otto Riedl

Medical University of Vienna

Stefan Salminger

Medical University of Vienna

Florian Frommlet

Medical University of Vienna

Gregory H. Borschel

Hospital for Sick Children University of Toronto

Dario Farina

Imperial College London

Oskar C. Aszmann

Medical University of Vienna

Science advances

2375-2548 (eISSN)

Vol. 5 1 eaau2956

Subject Categories

Basic Medicine

Clinical Medicine

Medical Biotechnology

DOI

10.1126/sciadv.aau2956

More information

Latest update

4/1/2021 1